Current therapies in treatment and prevention of fracture wound biofilms: why a multifaceted approach is essential for resolving persistent infections

Blanchette, Krystle A.; Wenke, Joseph C.

doi:https://doi.org/10.7150/jbji.23423

Articles | Volume 3, issue 2

Article
Metrics
Related articles

Articles | Volume 3, issue 2

https://doi.org/10.7150/jbji.23423

Articles | Volume 3, issue 2

Article
Metrics
Related articles

Review

12 Apr 2018

Review |

| 12 Apr 2018

Current therapies in treatment and prevention of fracture wound biofilms: why a multifaceted approach is essential for resolving persistent infections

Krystle A. Blanchette and Joseph C. Wenke

Krystle A. Blanchette

US Army Institute of Surgical Research, Ft Sam Houston, TX

Joseph C. Wenke

US Army Institute of Surgical Research, Ft Sam Houston, TX

Cited articles

Cross JD, Ficke JR, Hsu JR, Masini BD, Wenke JC. Battlefield orthopaedic injuries cause the majority of long-term disabilities. J Am Acad Orthop Surg. 2011;19(Suppl 1):S1–7.

Owens BD, Kragh JF Jr, Wenke JC, Macaitis J, Wade CE, Holcomb JB. Combat wounds in operation Iraqi Freedom and operation Enduring Freedom. J Trauma. 2008;64:295–9.

Masini BD, Owens BD, Hsu JR, Wenke JC. Rehospitalization after combat injury. J Trauma. 2011;71:S98–102.

Masini BD, Waterman SM, Wenke JC, Owens BD, Hsu JR, Ficke JR. Resource utilization and disability outcome assessment of combat casualties from Operation Iraqi Freedom and Operation Enduring Freedom. J Orthop Trauma. 2009;23:261–6.

Santolini E, West R, Giannoudis PV. Risk factors for long bone fracture non-union: a stratification approach based on the level of the existing scientific evidence. Injury. 2015;46(Suppl 8):S8–S19.

Sanchez CJ Jr, Mende K, Beckius ML, Akers KS, Romano DR, Wenke JC. et al. Biofilm formation by clinical isolates and the implications in chronic infections. BMC Infect Dis. 2013;13:47. [PMC free article]

Kwiecinski J, Kahlmeter G, Jin T. Biofilm formation by Staphylococcus aureus isolates from skin and soft tissue infections. Curr Microbiol. 2015;70:698–703.

James GA, Swogger E, Wolcott R, Pulcini E, Secor P, Sestrich J. et al. Biofilms in chronic wounds. Wound Repair Regen. 2008;16:37–44.

Chen AT, Vallier HA. Noncontiguous and open fractures of the lower extremity: Epidemiology, complications, and unplanned procedures. Injury. 2016;47:742–7.

Johnson EN, Burns TC, Hayda RA, Hospenthal DR, Murray CK. Infectious complications of open type III tibial fractures among combat casualties. Clin Infect Dis. 2007;45:409–15.

Murray CK, Obremskey WT, Hsu JR, Andersen RC, Calhoun JH, Clasper JC. et al. Prevention of infections associated with combat-related extremity injuries. J Trauma. 2011;71:S235–57.

Sanchez CJ Jr, Akers KS, Romano DR, Woodbury RL, Hardy SK, Murray CK. et al. D-amino acids enhance the activity of antimicrobials against biofilms of clinical wound isolates of Staphylococcus aureus and Pseudomonas aeruginosa. Antimicrob Agents Chemother. 2014;58:4353–61. [PMC free article]

Blanchette-Cain K, Hinojosa CA, Akula Suresh Babu R, Lizcano A, Gonzalez-Juarbe N, Munoz-Almagro C. et al. Streptococcus pneumoniae biofilm formation is strain dependent, multifactorial, and associated with reduced invasiveness and immunoreactivity during colonization. MBio. 2013;4:e00745–13. [PMC free article]

Flemming HC, Wingender J. The biofilm matrix. Nat Rev Microbiol. 2010;8:623–33.

Becker P, Hufnagle W, Peters G, Herrmann M. Detection of differential gene expression in biofilm-forming versus planktonic populations of Staphylococcus aureus using micro-representational-difference analysis. Appl Environ Microbiol. 2001;67:2958–65. [PMC free article]

Beenken KE, Dunman PM, McAleese F, Macapagal D, Murphy E, Projan SJ. et al. Global gene expression in Staphylococcus aureus biofilms. J Bacteriol. 2004;186:4665–84. [PMC free article]

Pabst B, Pitts B, Lauchnor E, Stewart PS. Gel-Entrapped Staphylococcus aureus Bacteria as Models of Biofilm Infection Exhibit Growth in Dense Aggregates, Oxygen Limitation, Antibiotic Tolerance, and Heterogeneous Gene Expression. Antimicrob Agents Chemother. 2016;60:6294–301. [PMC free article]

Lewis K. Persister cells: molecular mechanisms related to antibiotic tolerance. Handb Exp Pharmacol; 2012. pp. 121–33.

Percival SL, Hill KE, Malic S, Thomas DW, Williams DW. Antimicrobial tolerance and the significance of persister cells in recalcitrant chronic wound biofilms. Wound Repair Regen. 2011;19:1–9.

Lewis K. Persister cells and the riddle of biofilm survival. Biochemistry (Mosc) 2005;70:267–74.

Walters MC 3rd, Roe F, Bugnicourt A, Franklin MJ, Stewart PS. Contributions of antibiotic penetration, oxygen limitation, and low metabolic activity to tolerance of Pseudomonas aeruginosa biofilms to ciprofloxacin and tobramycin. Antimicrob Agents Chemother. 2003;47:317–23. [PMC free article]

Brown MR, Allison DG, Gilbert P. Resistance of bacterial biofilms to antibiotics: a growth-rate related effect? J Antimicrob Chemother. 1988;22:777–80.

Madsen JS, Burmolle M, Hansen LH, Sorensen SJ. The interconnection between biofilm formation and horizontal gene transfer. FEMS Immunol Med Microbiol. 2012;65:183–95.

Aguila-Arcos S, Alvarez-Rodriguez I, Garaiyurrebaso O, Garbisu C, Grohmann E, Alkorta I. Biofilm-Forming Clinical Staphylococcus Isolates Harbor Horizontal Transfer and Antibiotic Resistance Genes. Front Microbiol. 2017;8:2018. [PMC free article]

Wettero J, Tengvall P, Bengtsson T. Platelets stimulated by IgG-coated surfaces bind and activate neutrophils through a selectin-dependent pathway. Biomaterials. 2003;24:1559–73.

Leid JG, Shirtliff ME, Costerton JW, Stoodley P. Human leukocytes adhere to, penetrate, and respond to Staphylococcus aureus biofilms. Infect Immun. 2002;70:6339–45. [PMC free article]

Winkler H. Treatment of chronic orthopaedic infection. EFORT Open Rev. 2017;2:110–6. [PMC free article]

McConoughey SJ, Howlin R, Granger JF, Manring MM, Calhoun JH, Shirtliff M. et al. Biofilms in periprosthetic orthopedic infections. Future Microbiol. 2014;9:987–1007. [PMC free article]

Percival SL. Importance of biofilm formation in surgical infection. Br J Surg. 2017;104:e85–e94.

Schultz GS, Sibbald RG, Falanga V, Ayello EA, Dowsett C, Harding K. et al. Wound bed preparation: a systematic approach to wound management. Wound Repair Regen. 2003;11(Suppl 1):S1–28.

Harries RL, Bosanquet DC, Harding KG. Wound bed preparation: TIME for an update. Int Wound J. 2016;13(Suppl 3):8–14.

Hassinger SM, Harding G, Wongworawat MD. High-pressure pulsatile lavage propagates bacteria into soft tissue. Clin Orthop Relat Res. 2005;439:27–31.

Sibbald RG, Williamson D, Orsted HL, Campbell K, Keast D, Krasner D. et al. Preparing the wound bed-debridement, bacterial balance, and moisture balance. Ostomy Wound Manage. 2000;46:14–22. 4-8, 30-5; quiz 6-7.

Bowler PG, Jones SA, Davies BJ, Coyle E. Infection control properties of some wound dressings. J Wound Care. 1999;8:499–502.

Percival SL, Slone W, Linton S, Okel T, Corum L, Thomas JG. The antimicrobial efficacy of a silver alginate dressing against a broad spectrum of clinically relevant wound isolates. Int Wound J. 2011;8:237–43.

Meaume S, Vallet D, Morere MN, Teot L. Evaluation of a silver-releasing hydroalginate dressing in chronic wounds with signs of local infection. J Wound Care. 2005;14:411–9.

Schultz GS, Barillo DJ, Mozingo DW, Chin GA, Wound Bed Advisory Board M. Wound bed preparation and a brief history of TIME. Int Wound J. 2004;1:19–32.

Brotz-Oesterhelt H, Beyer D, Kroll HP, Endermann R, Ladel C, Schroeder W. et al. Dysregulation of bacterial proteolytic machinery by a new class of antibiotics. Nat Med. 2005;11:1082–7.

Conlon BP, Nakayasu ES, Fleck LE, LaFleur MD, Isabella VM, Coleman K. et al. Activated ClpP kills persisters and eradicates a chronic biofilm infection. Nature. 2013;503:365–70. [PMC free article]

Molina-Manso D, del Prado G, Ortiz-Perez A, Manrubia-Cobo M, Gomez-Barrena E, Cordero-Ampuero J. et al. In vitro susceptibility to antibiotics of staphylococci in biofilms isolated from orthopaedic infections. Int J Antimicrob Agents. 2013;41:521–3.

Sanchez CJ Jr, Shiels SM, Tennent DJ, Hardy SK, Murray CK, Wenke JC. Rifamycin Derivatives Are Effective Against Staphylococcal Biofilms In Vitro and Elutable From PMMA. Clin Orthop Relat Res. 2015;473:2874–84. [PMC free article]

Rose WE, Otto DP, Aucamp ME, Miller Z, de Villiers MM. Prevention of biofilm formation by methacrylate-based copolymer films loaded with rifampin, clarithromycin, doxycycline alone or in combination. Pharm Res. 2015;32:61–73.

Ozturk I, Yurtman AN, Erac B, Gul-Yurtsever S, Ermertcan S, Hosgor-Limoncu M. In vitro effect of moxifloxacin and rifampicin on biofilm formation by clinical MRSA isolates. Bratisl Lek Listy. 2014;115:483–6.

Fazly Bazzaz BS, Khameneh B, Zarei H, Golmohammadzadeh S. Antibacterial efficacy of rifampin loaded solid lipid nanoparticles against Staphylococcus epidermidis biofilm. Microb Pathog. 2016;93:137–44.

Siala W, Mingeot-Leclercq MP, Tulkens PM, Hallin M, Denis O, Van Bambeke F. Comparison of the antibiotic activities of Daptomycin, Vancomycin, and the investigational Fluoroquinolone Delafloxacin against biofilms from Staphylococcus aureus clinical isolates. Antimicrob Agents Chemother. 2014;58:6385–97. [PMC free article]

Ferreira IS, Bettencourt AF, Goncalves LM, Kasper S, Betrisey B, Kikhney J. et al. Activity of daptomycin- and vancomycin-loaded poly-epsilon-caprolactone microparticles against mature staphylococcal biofilms. Int J Nanomedicine. 2015;10:4351–66. [PMC free article]

Du J, Bandara HM, Du P, Huang H, Hoang K, Nguyen D. et al. Improved Biofilm Antimicrobial Activity of Polyethylene Glycol Conjugated Tobramycin Compared to Tobramycin in Pseudomonas aeruginosa Biofilms. Mol Pharm. 2015;12:1544–53.

Kennedy S, Beaudoin T, Yau YC, Caraher E, Zlosnik JE, Speert DP. et al. Activity of Tobramycin against Cystic Fibrosis Isolates of Burkholderia cepacia Complex Grown as Biofilms. Antimicrob Agents Chemother. 2015;60:348–55. [PMC free article]

Dunne WM Jr. Bacterial adhesion: seen any good biofilms lately? Clin Microbiol Rev. 2002;15:155–66. [PMC free article]

Costerton JW, Stewart PS, Greenberg EP. Bacterial biofilms: a common cause of persistent infections. Science. 1999;284:1318–22.

Stewart PS, Costerton JW. Antibiotic resistance of bacteria in biofilms. Lancet. 2001;358:135–8.

Yasuda H, Ajiki Y, Koga T, Kawada H, Yokota T. Interaction between biofilms formed by Pseudomonas aeruginosa and clarithromycin. Antimicrob Agents Chemother. 1993;37:1749–55. [PMC free article]

Singh R, Ray P, Das A, Sharma M. Penetration of antibiotics through Staphylococcus aureus and Staphylococcus epidermidis biofilms. J Antimicrob Chemother. 2010;65:1955–8.

Stone G, Wood P, Dixon L, Keyhan M, Matin A. Tetracycline rapidly reaches all the constituent cells of uropathogenic Escherichia coli biofilms. Antimicrob Agents Chemother. 2002;46:2458–61. [PMC free article]

Ferguson J, Diefenbeck M, McNally M. Ceramic Biocomposites as Biodegradable Antibiotic Carriers in the Treatment of Bone Infections. J Bone Jt Infect. 2017;2:38–51. [PMC free article]

Fang C, Wong TM, Lau TW, To KK, Wong SS, Leung F. Infection after fracture osteosynthesis - Part I. J Orthop Surg (Hong Kong) 2017;25:2309499017692712.

Fang C, Wong TM, To KK, Wong SS, Lau TW, Leung F. Infection after fracture osteosynthesis - Part II. J Orthop Surg (Hong Kong) 2017;25:2309499017692714.

Yoon HK, Cho SH, Lee DY, Kang BH, Lee SH, Moon DG. et al. A Review of the Literature on Culture-Negative Periprosthetic Joint Infection: Epidemiology, Diagnosis and Treatment. Knee Surg Relat Res. 2017;29:155–64. [PMC free article]

White LM, Schweitzer ME, Deely DM, Gannon F. Study of osteomyelitis: utility of combined histologic and microbiologic evaluation of percutaneous biopsy samples. Radiology. 1995;197:840–2.

Floyed RL, Steele RW. Culture-negative osteomyelitis. Pediatr Infect Dis J. 2003;22:731–6.

Termaat MF, Raijmakers PG, Scholten HJ, Bakker FC, Patka P, Haarman HJ. The accuracy of diagnostic imaging for the assessment of chronic osteomyelitis: a systematic review and meta-analysis. J Bone Joint Surg Am. 2005;87:2464–71.

Minassian AM, Newnham R, Kalimeris E, Bejon P, Atkins BL, Bowler IC. Use of an automated blood culture system (BD BACTEC) for diagnosis of prosthetic joint infections: easy and fast. BMC Infect Dis. 2014;14:233. [PMC free article]

Achermann Y, Vogt M, Leunig M, Wust J, Trampuz A. Improved diagnosis of periprosthetic joint infection by multiplex PCR of sonication fluid from removed implants. J Clin Microbiol. 2010;48:1208–14. [PMC free article]

Tzeng A, Tzeng TH, Vasdev S, Korth K, Healey T, Parvizi J. et al. Treating periprosthetic joint infections as biofilms: key diagnosis and management strategies. Diagn Microbiol Infect Dis. 2015;81:192–200.

Mariaux S, Tafin UF, Borens O. Diagnosis Of Persistent Infection In Prosthetic Two-Stage Exchange: PCR analysis of Sonication fluid From Bone Cement Spacers. J Bone Jt Infect. 2017;2:218–23. [PMC free article]

Jacovides CL, Kreft R, Adeli B, Hozack B, Ehrlich GD, Parvizi J. Successful identification of pathogens by polymerase chain reaction (PCR)-based electron spray ionization time-of-flight mass spectrometry (ESI-TOF-MS) in culture-negative periprosthetic joint infection. J Bone Joint Surg Am. 2012;94:2247–54.

Bizzini A, Greub G. Matrix-assisted laser desorption ionization time-of-flight mass spectrometry, a revolution in clinical microbial identification. Clin Microbiol Infect. 2010;16:1614–9.

Bizzini A, Durussel C, Bille J, Greub G, Prod'hom G. Performance of matrix-assisted laser desorption ionization-time of flight mass spectrometry for identification of bacterial strains routinely isolated in a clinical microbiology laboratory. J Clin Microbiol. 2010;48:1549–54. [PMC free article]

Tetz VV, Tetz GV. Effect of extracellular DNA destruction by DNase I on characteristics of forming biofilms. DNA Cell Biol. 2010;29:399–405.

Nguyen UT, Burrows LL. DNase I and proteinase K impair Listeria monocytogenes biofilm formation and induce dispersal of pre-existing biofilms. Int J Food Microbiol. 2014;187:26–32.

Kaplan JB, LoVetri K, Cardona ST, Madhyastha S, Sadovskaya I, Jabbouri S. et al. Recombinant human DNase I decreases biofilm and increases antimicrobial susceptibility in staphylococci. J Antibiot (Tokyo) 2012;65:73–7. [PMC free article]

Baelo A, Levato R, Julian E, Crespo A, Astola J, Gavalda J. et al. Disassembling bacterial extracellular matrix with DNase-coated nanoparticles to enhance antibiotic delivery in biofilm infections. J Control Release. 2015;209:150–8.

Shak S. Aerosolized recombinant human DNase I for the treatment of cystic fibrosis. Chest. 1995;107:65S–70S.

Sawicki GS, Chou W, Raimundo K, Trzaskoma B, Konstan MW. Randomized trial of efficacy and safety of dornase alfa delivered by eRapid nebulizer in cystic fibrosis patients. J Cyst Fibros. 2015;14:777–83.

Shak S, Capon DJ, Hellmiss R, Marsters SA, Baker CL. Recombinant human DNase I reduces the viscosity of cystic fibrosis sputum. Proc Natl Acad Sci U S A. 1990;87:9188–92. [PMC free article]

Hymes SR, Randis TM, Sun TY, Ratner AJ. DNase inhibits Gardnerella vaginalis biofilms in vitro and in vivo. J Infect Dis. 2013;207:1491–7. [PMC free article]

Conover MS, Mishra M, Deora R. Extracellular DNA is essential for maintaining Bordetella biofilm integrity on abiotic surfaces and in the upper respiratory tract of mice. PLoS One. 2011;6:e16861. [PMC free article]

Loughran AJ, Atwood DN, Anthony AC, Harik NS, Spencer HJ, Beenken KE. et al. Impact of individual extracellular proteases on Staphylococcus aureus biofilm formation in diverse clinical isolates and their isogenic sarA mutants. Microbiologyopen. 2014;3:897–909. [PMC free article]

Craik CS, Page MJ, Madison EL. Proteases as therapeutics. Biochem J. 2011;435:1–16. [PMC free article]

Marti M, Trotonda MP, Tormo-Mas MA, Vergara-Irigaray M, Cheung AL, Lasa I. et al. Extracellular proteases inhibit protein-dependent biofilm formation in Staphylococcus aureus. Microbes Infect. 2010;12:55–64.

Chen C, Krishnan V, Macon K, Manne K, Narayana SV, Schneewind O. Secreted proteases control autolysin-mediated biofilm growth of Staphylococcus aureus. J Biol Chem. 2013;288:29440–52. [PMC free article]

Kerrigan JE, Ragunath C, Kandra L, Gyemant G, Liptak A, Janossy L. et al. Modeling and biochemical analysis of the activity of antibiofilm agent Dispersin B. Acta Biol Hung. 2008;59:439–51. [PMC free article]

Ramasubbu N, Thomas LM, Ragunath C, Kaplan JB. Structural analysis of dispersin B, a biofilm-releasing glycoside hydrolase from the periodontopathogen Actinobacillus actinomycetemcomitans. J Mol Biol. 2005;349:475–86.

Brindle ER, Miller DA, Stewart PS. Hydrodynamic deformation and removal of Staphylococcus epidermidis biofilms treated with urea, chlorhexidine, iron chloride, or DispersinB. Biotechnol Bioeng. 2011;108:2968–77.

Varposhti M, Abdi Ali A, Mohammadi P. Synergistic Effects of Bismuth Thiols and Various Antibiotics Against Pseudomonas aeruginosa Biofilm. Jundishapur J Microbiol. 2014;7:e9142. [PMC free article]

Folsom JP, Baker B, Stewart PS. In vitro efficacy of bismuth thiols against biofilms formed by bacteria isolated from human chronic wounds. J Appl Microbiol. 2011;111:989–96.

Waters CM, Bassler BL. Quorum sensing: cell-to-cell communication in bacteria. Annu Rev Cell Dev Biol. 2005;21:319–46.

Brackman G, Coenye T. Quorum sensing inhibitors as anti-biofilm agents. Curr Pharm Des. 2015;21:5–11.

Kimyon O, Uluturk ZI, Nizalapur S, Lee M, Kutty SK, Beckmann S. et al. N-Acetylglucosamine Inhibits LuxR, LasR and CviR Based Quorum Sensing Regulated Gene Expression Levels. Front Microbiol. 2016;7:1313. [PMC free article]

Biswas NN, Yu TT, Kimyon O, Nizalapur S, Gardner CR, Manefield M. et al. Synthesis of antimicrobial glucosamides as bacterial quorum sensing mechanism inhibitors. Bioorg Med Chem. 2017;25:1183–94.

Girennavar B, Cepeda ML, Soni KA, Vikram A, Jesudhasan P, Jayaprakasha GK. et al. Grapefruit juice and its furocoumarins inhibits autoinducer signaling and biofilm formation in bacteria. Int J Food Microbiol. 2008;125:204–8.

Tung TT, Jakobsen TH, Dao TT, Fuglsang AT, Givskov M, Christensen SB. et al. Fusaric acid and analogues as Gram-negative bacterial quorum sensing inhibitors. Eur J Med Chem. 2017;126:1011–20.

Xu X, Zhou XD, Wu CD. Tea catechin epigallocatechin gallate inhibits Streptococcus mutans biofilm formation by suppressing gtf genes. Arch Oral Biol. 2012;57:678–83.

Lee P, Tan KS. Effects of Epigallocatechin gallate against Enterococcus faecalis biofilm and virulence. Arch Oral Biol. 2015;60:393–9.

Asahi Y, Noiri Y, Miura J, Maezono H, Yamaguchi M, Yamamoto R. et al. Effects of the tea catechin epigallocatechin gallate on Porphyromonas gingivalis biofilms. J Appl Microbiol. 2014;116:1164–71.

Brackman G, Cos P, Maes L, Nelis HJ, Coenye T. Quorum sensing inhibitors increase the susceptibility of bacterial biofilms to antibiotics in vitro and in vivo. Antimicrob Agents Chemother. 2011;55:2655–61. [PMC free article]

Green B, Elhamshary A, Gomez R, Rahimi S, Brennan PA. An update on the current management of head and neck mucosal melanoma. J Oral Pathol Med. 2017;46:475–9.

Giacometti A, Cirioni O, Gov Y, Ghiselli R, Del Prete MS, Mocchegiani F. et al. RNA III inhibiting peptide inhibits in vivo biofilm formation by drug-resistant Staphylococcus aureus. Antimicrob Agents Chemother. 2003;47:1979–83. [PMC free article]

Kiran MD, Adikesavan NV, Cirioni O, Giacometti A, Silvestri C, Scalise G. et al. Discovery of a quorum-sensing inhibitor of drug-resistant staphylococcal infections by structure-based virtual screening. Mol Pharmacol. 2008;73:1578–86.

Yang S, Abdel-Razek OA, Cheng F, Bandyopadhyay D, Shetye GS, Wang G. et al. Bicyclic brominated furanones: a new class of quorum sensing modulators that inhibit bacterial biofilm formation. Bioorg Med Chem. 2014;22:1313–7. [PMC free article]

Niu C, Afre S, Gilbert ES. Subinhibitory concentrations of cinnamaldehyde interfere with quorum sensing. Lett Appl Microbiol. 2006;43:489–94.

Kim SG, Yoon YH, Choi JW, Rha KS, Park YH. Effect of furanone on experimentally induced Pseudomonas aeruginosa biofilm formation: in vitro study. Int J Pediatr Otorhinolaryngol. 2012;76:1575–8.

He Z, Wang Q, Hu Y, Liang J, Jiang Y, Ma R. et al. Use of the quorum sensing inhibitor furanone C-30 to interfere with biofilm formation by Streptococcus mutans and its luxS mutant strain. Int J Antimicrob Agents. 2012;40:30–5.

Brackman G, Defoirdt T, Miyamoto C, Bossier P, Van Calenbergh S, Nelis H. et al. Cinnamaldehyde and cinnamaldehyde derivatives reduce virulence in Vibrio spp. by decreasing the DNA-binding activity of the quorum sensing response regulator LuxR. BMC Microbiol. 2008;8:149. [PMC free article]

Beema Shafreen RM, Selvaraj C, Singh SK, Karutha Pandian S. In silico and in vitro studies of cinnamaldehyde and their derivatives against LuxS in Streptococcus pyogenes: effects on biofilm and virulence genes. J Mol Recognit. 2014;27:106–16.

Jakobsen TH, van Gennip M, Phipps RK, Shanmugham MS, Christensen LD, Alhede M. et al. Ajoene, a sulfur-rich molecule from garlic, inhibits genes controlled by quorum sensing. Antimicrob Agents Chemother. 2012;56:2314–25. [PMC free article]

Christensen LD, van Gennip M, Jakobsen TH, Alhede M, Hougen HP, Hoiby N. et al. Synergistic antibacterial efficacy of early combination treatment with tobramycin and quorum-sensing inhibitors against Pseudomonas aeruginosa in an intraperitoneal foreign-body infection mouse model. J Antimicrob Chemother. 2012;67:1198–206.

Cirioni O, Giacometti A, Ghiselli R, Dell'Acqua G, Orlando F, Mocchegiani F. et al. RNAIII-inhibiting peptide significantly reduces bacterial load and enhances the effect of antibiotics in the treatment of central venous catheter-associated Staphylococcus aureus infections. J Infect Dis. 2006;193:180–6.

Harmata AJ, Ma Y, Sanchez CJ, Zienkiewicz KJ, Elefteriou F, Wenke JC. et al. D-amino acid inhibits biofilm but not new bone formation in an ovine model. Clin Orthop Relat Res. 2015;473:3951–61. [PMC free article]

Kolodkin-Gal I, Romero D, Cao S, Clardy J, Kolter R, Losick R. D-amino acids trigger biofilm disassembly. Science. 2010;328:627–9. [PMC free article]

Duong HT, Jung K, Kutty SK, Agustina S, Adnan NN, Basuki JS. et al. Nanoparticle (star polymer) delivery of nitric oxide effectively negates Pseudomonas aeruginosa biofilm formation. Biomacromolecules. 2014;15:2583–9.

Barraud N, Kelso MJ, Rice SA, Kjelleberg S. Nitric oxide: a key mediator of biofilm dispersal with applications in infectious diseases. Curr Pharm Des. 2015;21:31–42.

Davies DG, Marques CN. A fatty acid messenger is responsible for inducing dispersion in microbial biofilms. J Bacteriol. 2009;191:1393–403. [PMC free article]

Marques CN, Davies DG, Sauer K. Control of Biofilms with the Fatty Acid Signaling Molecule cis-2-Decenoic Acid. Pharmaceuticals (Basel) 2015;8:816–35. [PMC free article]

Wake N, Asahi Y, Noiri Y, Hayashi M, Motooka D, Nakamura S. et al. Temporal dynamics of bacterial microbiota in the human oral cavity determined using an in situ model of dental biofilms. NPJ Biofilms Microbiomes. 2016;2:16018. [PMC free article]

Speziale P, Pietrocola G, Foster TJ, Geoghegan JA. Protein-based biofilm matrices in Staphylococci. Front Cell Infect Microbiol. 2014;4:171. [PMC free article]

Formosa-Dague C, Feuillie C, Beaussart A, Derclaye S, Kucharikova S, Lasa I. et al. Sticky Matrix: Adhesion Mechanism of the Staphylococcal Polysaccharide Intercellular Adhesin. ACS Nano. 2016;10:3443–52.

Hofmann CM, Bednar KJ, Anderson JM, Marchant RE. Disruption of Staphylococcus epidermidis biofilm formation using a targeted cationic peptide. J Biomed Mater Res A. 2012;100:1061–7.

Paharik AE, Horswill AR. The Staphylococcal Biofilm: Adhesins, Regulation, and Host Response. Microbiol Spectr; 2016. p. 4. [PMC free article]

Herman-Bausier P, El-Kirat-Chatel S, Foster TJ, Geoghegan JA, Dufrene YF. Staphylococcus aureus Fibronectin-Binding Protein A Mediates Cell-Cell Adhesion through Low-Affinity Homophilic Bonds. MBio. 2015;6:e00413–15. [PMC free article]

Schaeffer CR, Woods KM, Longo GM, Kiedrowski MR, Paharik AE, Buttner H. et al. Accumulation-associated protein enhances Staphylococcus epidermidis biofilm formation under dynamic conditions and is required for infection in a rat catheter model. Infect Immun. 2015;83:214–26. [PMC free article]

Conlon BP, Geoghegan JA, Waters EM, McCarthy H, Rowe SE, Davies JR. et al. Role for the A domain of unprocessed accumulation-associated protein (Aap) in the attachment phase of the Staphylococcus epidermidis biofilm phenotype. J Bacteriol. 2014;196:4268–75. [PMC free article]

Christner M, Franke GC, Schommer NN, Wendt U, Wegert K, Pehle P. et al. The giant extracellular matrix-binding protein of Staphylococcus epidermidis mediates biofilm accumulation and attachment to fibronectin. Mol Microbiol. 2010;75:187–207.

Loehfelm TW, Luke NR, Campagnari AA. Identification and characterization of an Acinetobacter baumannii biofilm-associated protein. J Bacteriol. 2008;190:1036–44. [PMC free article]

Lasa I, Penades JR. Bap: a family of surface proteins involved in biofilm formation. Res Microbiol. 2006;157:99–107.

Yang YH, Jiang YL, Zhang J, Wang L, Bai XH, Zhang SJ. et al. Structural insights into SraP-mediated Staphylococcus aureus adhesion to host cells. PLoS Pathog. 2014;10:e1004169. [PMC free article]

Khodaparast L, Khodaparast L, Shahrooei M, Stijlemans B, Merckx R, Baatsen P. et al. The Possible Role of Staphylococcus epidermidis LPxTG Surface Protein SesC in Biofilm Formation. PLoS One. 2016;11:e0146704. [PMC free article]

Chung L, Dinakarpandian D, Yoshida N, Lauer-Fields JL, Fields GB, Visse R. et al. Collagenase unwinds triple-helical collagen prior to peptide bond hydrolysis. EMBO J. 2004;23:3020–30. [PMC free article]

Birkenhauer E, Neethirajan S, Weese JS. Collagen and hyaluronan at wound sites influence early polymicrobial biofilm adhesive events. BMC Microbiol. 2014;14:191. [PMC free article]

Smith RG. Enzymatic debriding agents: an evaluation of the medical literature. Ostomy Wound Manage. 2008;54:16–34.

Langer V, Bhandari PS, Rajagopalan S, Mukherjee MK. Enzymatic debridement of large burn wounds with papain-urea: Is it safe? Med J Armed Forces India. 2013;69:144–50. [PMC free article]

Watters CM, Burton T, Kirui DK, Millenbaugh NJ. Enzymatic degradation of in vitro Staphylococcus aureus biofilms supplemented with human plasma. Infect Drug Resist. 2016;9:71–8. [PMC free article]

Mugita N, Nambu T, Takahashi K, Wang PL, Komasa Y. Proteases, actinidin, papain and trypsin reduce oral biofilm on the tongue in elderly subjects and in vitro. Arch Oral Biol. 2017;82:233–40.

Maurer HR. Bromelain: biochemistry, pharmacology and medical use. Cell Mol Life Sci. 2001;58:1234–45.

Cetrulo GI. Use of trypsin intravenously in a gunshot wound. J Am Med Assoc. 1953;152:605–6.

Maresso AW, Wu R, Kern JW, Zhang R, Janik D, Missiakas DM. et al. Activation of inhibitors by sortase triggers irreversible modification of the active site. J Biol Chem. 2007;282:23129–39. [PMC free article]

Oh KB, Kim SH, Lee J, Cho WJ, Lee T, Kim S. Discovery of diarylacrylonitriles as a novel series of small molecule sortase A inhibitors. J Med Chem. 2004;47:2418–21.

Hu P, Huang P, Chen WM. Curcumin inhibits the Sortase A activity of the Streptococcus mutans UA159. Appl Biochem Biotechnol. 2013;171:396–402.

Harrison JJ, Turner RJ, Ceri H. Persister cells, the biofilm matrix and tolerance to metal cations in biofilm and planktonic Pseudomonas aeruginosa. Environ Microbiol. 2005;7:981–94.

Abraham NM, Lamlertthon S, Fowler VG, Jefferson KK. Chelating agents exert distinct effects on biofilm formation in Staphylococcus aureus depending on strain background: role for clumping factor B. J Med Microbiol. 2012;61:1062–70. [PMC free article]

Dunne WM Jr, Burd EM. The effects of magnesium, calcium, EDTA, and pH on the in vitro adhesion of Staphylococcus epidermidis to plastic. Microbiol Immunol. 1992;36:1019–27.

Lin MH, Shu JC, Huang HY, Cheng YC. Involvement of iron in biofilm formation by Staphylococcus aureus. PLoS One. 2012;7:e34388. [PMC free article]

Sarkisova S, Patrauchan MA, Berglund D, Nivens DE, Franklin MJ. Calcium-induced virulence factors associated with the extracellular matrix of mucoid Pseudomonas aeruginosa biofilms. J Bacteriol. 2005;187:4327–37. [PMC free article]

Kamiya H, Ehara T, Matsumoto T. Inhibitory effects of lactoferrin on biofilm formation in clinical isolates of Pseudomonas aeruginosa. J Infect Chemother. 2012;18:47–52.

Dashper SG, Pan Y, Veith PD, Chen YY, Toh EC, Liu SW. et al. Lactoferrin inhibits Porphyromonas gingivalis proteinases and has sustained biofilm inhibitory activity. Antimicrob Agents Chemother. 2012;56:1548–56. [PMC free article]

Allison LM, Walker LA, Sanders BJ, Yang Z, Eckert G, Gregory RL. Effect of Human Milk and its Components on Streptococcus Mutans Biofilm Formation. J Clin Pediatr Dent. 2015;39:255–61.

Ammons MC, Copie V. Mini-review: Lactoferrin: a bioinspired, anti-biofilm therapeutic. Biofouling. 2013;29:443–55. [PMC free article]

Liesse Iyamba JM, Seil M, Nagant C, Dulanto S, Deplano A, El Khattabi C. et al. Inhibition by EGTA of the formation of a biofilm by clinical strains of Staphylococcus aureus. J Basic Microbiol. 2014;54:700–10.

Finnegan S, Percival SL. EDTA: An Antimicrobial and Antibiofilm Agent for Use in Wound Care. Adv Wound Care (New Rochelle) 2015;4:415–21. [PMC free article]

Liu Z, Lin Y, Lu Q, Li F, Yu J, Wang Z. et al. In vitro and in vivo activity of EDTA and antibacterial agents against the biofilm of mucoid Pseudomonas aeruginosa. Infection. 2017;45:23–31.

Zenga J, Gagnon PM, Vogel J, Chole RA. Biofilm formation by otopathogenic strains of Pseudomonas aeruginosa is not consistently inhibited by ethylenediaminetetraacetic acid. Otol Neurotol. 2012;33:1007–12. [PMC free article]

Alexander JW. History of the medical use of silver. Surg Infect (Larchmt) 2009;10:289–92.

Markowska K, Grudniak AM, Wolska KI. Silver nanoparticles as an alternative strategy against bacterial biofilms. Acta Biochim Pol. 2013;60:523–30.

Goggin R, Jardeleza C, Wormald PJ, Vreugde S. Colloidal silver: a novel treatment for Staphylococcus aureus biofilms? Int Forum Allergy Rhinol. 2014;4:171–5.

Rajiv S, Drilling A, Bassiouni A, James C, Vreugde S, Wormald PJ. Topical colloidal silver as an anti-biofilm agent in a Staphylococcus aureus chronic rhinosinusitis sheep model. Int Forum Allergy Rhinol. 2015;5:283–8.

Li X, Robinson SM, Gupta A, Saha K, Jiang Z, Moyano DF. et al. Functional gold nanoparticles as potent antimicrobial agents against multi-drug-resistant bacteria. ACS Nano. 2014;8:10682–6. [PMC free article]

Boda SK, Broda J, Schiefer F, Weber-Heynemann J, Hoss M, Simon U. et al. Cytotoxicity of Ultrasmall Gold Nanoparticles on Planktonic and Biofilm Encapsulated Gram-Positive Staphylococci. Small. 2015;11:3183–93.

Dizaj SM, Lotfipour F, Barzegar-Jalali M, Zarrintan MH, Adibkia K. Antimicrobial activity of the metals and metal oxide nanoparticles. Mater Sci Eng C Mater Biol Appl. 2014;44:278–84.

Giri K, Yepes LR, Duncan B, Parameswaran PK, Yan B, Jiang Y. et al. Targeting bacterial biofilms via surface engineering of gold nanoparticles. RSC Adv. 2015;5:105551–9. [PMC free article]

Richter K, Thomas N, Zhang G, Prestidge CA, Coenye T, Wormald PJ. et al. Deferiprone and Gallium-Protoporphyrin Have the Capacity to Potentiate the Activity of Antibiotics in Staphylococcus aureus Small Colony Variants. Front Cell Infect Microbiol. 2017;7:280. [PMC free article]

LewisOscar F, MubarakAli D, Nithya C, Priyanka R, Gopinath V, Alharbi NS. et al. One pot synthesis and anti-biofilm potential of copper nanoparticles (CuNPs) against clinical strains of Pseudomonas aeruginosa. Biofouling. 2015;31:379–91.

Ahire JJ, Hattingh M, Neveling DP, Dicks LM. Copper-Containing Anti-Biofilm Nanofiber Scaffolds as a Wound Dressing Material. PLoS One. 2016;11:e0152755. [PMC free article]

Yadollahi M, Farhoudian S, Namazi H. One-pot synthesis of antibacterial chitosan/silver bio-nanocomposite hydrogel beads as drug delivery systems. Int J Biol Macromol. 2015;79:37–43.

Ahangari A, Salouti M, Heidari Z, Kazemizadeh AR, Safari AA. Development of gentamicin-gold nanospheres for antimicrobial drug delivery to Staphylococcal infected foci. Drug Deliv. 2013;20:34–9.

Rastogi L, Kora AJ, J A. Highly stable, protein capped gold nanoparticles as effective drug delivery vehicles for amino-glycosidic antibiotics. Mater Sci Eng C Mater Biol Appl. 2012;32:1571–7.

Zimmerli W, Sendi P. Orthopaedic biofilm infections. APMIS. 2017;125:353–64.

Rightmire E, Zurakowski D, Vrahas M. Acute infections after fracture repair: management with hardware in place. Clin Orthop Relat Res. 2008;466:466–72. [PMC free article]

Mantripragada VP, Lecka-Czernik B, Ebraheim NA, Jayasuriya AC. An overview of recent advances in designing orthopedic and craniofacial implants. J Biomed Mater Res A. 2013;101:3349–64. [PMC free article]

Ferraris S, Spriano S. Antibacterial titanium surfaces for medical implants. Mater Sci Eng C Mater Biol Appl. 2016;61:965–78.

Yeo IS, Kim HY, Lim KS, Han JS. Implant surface factors and bacterial adhesion: a review of the literature. Int J Artif Organs. 2012;35:762–72.

Clauss M, Graf S, Gersbach S, Hintermann B, Ilchmann T, Knupp M. Material and biofilm load of K wires in toe surgery: titanium versus stainless steel. Clin Orthop Relat Res. 2013;471:2312–7. [PMC free article]

Banovetz JM, Sharp R, Probe RA, Anglen JO. Titanium plate fixation: a review of implant failures. J Orthop Trauma. 1996;10:389–94.

Uhthoff HK, Bardos DI, Liskova-Kiar M. The advantages of titanium alloy over stainless steel plates for the internal fixation of fractures. An experimental study in dogs. J Bone Joint Surg Br. 1981;63B:427–84.

Koseki H, Yonekura A, Shida T, Yoda I, Horiuchi H, Morinaga Y. et al. Early staphylococcal biofilm formation on solid orthopaedic implant materials: in vitro study. PLoS One. 2014;9:e107588. [PMC free article]

Rotini R, Cavaciocchi M, Fabbri D, Bettelli G, Catani F, Campochiaro G. et al. Proximal humeral fracture fixation: multicenter study with carbon fiber peek plate. Musculoskelet Surg. 2015;99(Suppl 1):S1–8.

Schildhauer TA, Robie B, Muhr G, Koller M. Bacterial adherence to tantalum versus commonly used orthopedic metallic implant materials. J Orthop Trauma. 2006;20:476–84.

Schmidlin PR, Muller P, Attin T, Wieland M, Hofer D, Guggenheim B. Polyspecies biofilm formation on implant surfaces with different surface characteristics. J Appl Oral Sci. 2013;21:48–55. [PMC free article]

Burgers R, Gerlach T, Hahnel S, Schwarz F, Handel G, Gosau M. In vivo and in vitro biofilm formation on two different titanium implant surfaces. Clin Oral Implants Res. 2010;21:156–64.

Teughels W, Van Assche N, Sliepen I, Quirynen M. Effect of material characteristics and/or surface topography on biofilm development. Clin Oral Implants Res. 2006;17(Suppl 2):68–81.

Perez-Tanoira R, Aarnisalo AA, Eklund KK, Han X, Soininen A, Tiainen VM. et al. Prevention of Biomaterial Infection by Pre-Operative Incubation with Human Cells. Surg Infect (Larchmt) 2017;18:336–44.

Gristina AG. Biomaterial-centered infection: microbial adhesion versus tissue integration. Science. 1987;237:1588–95.

Subbiahdoss G, Grijpma DW, van der Mei HC, Busscher HJ, Kuijer R. Microbial biofilm growth versus tissue integration on biomaterials with different wettabilities and a polymer-brush coating. J Biomed Mater Res A. 2010;94:533–8.

Zhao B, van der Mei HC, Subbiahdoss G, de Vries J, Rustema-Abbing M, Kuijer R. et al. Soft tissue integration versus early biofilm formation on different dental implant materials. Dent Mater. 2014;30:716–27.

Moriarty TF, Kuehl R, Coenye T, Metsemakers WJ, Morgenstern M, Schwarz EM. et al. Orthopaedic device-related infection: current and future interventions for improved prevention and treatment. EFORT Open Rev. 2016;1:89–99. [PMC free article]

Alt V. Antimicrobial coated implants in trauma and orthopaedics-A clinical review and risk-benefit analysis. Injury. 2017;48:599–607.

Zhou X, Zhang J, Feng G, Shen J, Kong D, Zhao Q. Nitric Oxide-Releasing Biomaterials for Biomedical Applications. Curr Med Chem. 2016;23:2579–601.

Schaer TP, Stewart S, Hsu BB, Klibanov AM. Hydrophobic polycationic coatings that inhibit biofilms and support bone healing during infection. Biomaterials. 2012;33:1245–54.

Ma Y, Chen M, Jones JE, Ritts AC, Yu Q, Sun H. Inhibition of Staphylococcus epidermidis biofilm by trimethylsilane plasma coating. Antimicrob Agents Chemother. 2012;56:5923–37. [PMC free article]

Chen AF, Winkler H. Local Antimicrobial Treatment in Orthopaedic Surgery. J Bone Jt Infect. 2017;2:1–2. [PMC free article]

Peng ZX, Tu B, Shen Y, Du L, Wang L, Guo SR. et al. Quaternized chitosan inhibits icaA transcription and biofilm formation by Staphylococcus on a titanium surface. Antimicrob Agents Chemother. 2011;55:860–6. [PMC free article]

Carlson RP, Taffs R, Davison WM, Stewart PS. Anti-biofilm properties of chitosan-coated surfaces. J Biomater Sci Polym Ed. 2008;19:1035–46.

Paramasivan S, Jones D, Baker L, Hanton L, Robinson S, Wormald PJ. et al. The use of chitosan-dextran gel shows anti-inflammatory, antibiofilm, and antiproliferative properties in fibroblast cell culture. Am J Rhinol Allergy. 2014;28:361–5.

Nelson CL, Jones RB, Wingert NC, Foltzer M, Bowen TR. Sonication of antibiotic spacers predicts failure during two-stage revision for prosthetic knee and hip infections. Clin Orthop Relat Res. 2014;472:2208–14. [PMC free article]

Sanchez CJ, Hurtgen BJ, Lizcano A, Shivshankar P, Cole GT, Orihuela CJ. Biofilm and planktonic pneumococci demonstrate disparate immunoreactivity to human convalescent sera. BMC Microbiol. 2011;11:245. [PMC free article]

Blanchette KA, Prabhakara R, Shirtliff ME, Wenke JC. Inhibition of fracture healing in the presence of contamination by Staphylococcus aureus: Effects of growth state and immune response. J Orthop Res; 2017.

Lee BY, Wiringa AE, Bailey RR, Lewis GJ, Feura J, Muder RR. Staphylococcus aureus vaccine for orthopedic patients: an economic model and analysis. Vaccine. 2010;28:2465–71. [PMC free article]

Josefsson E, Hartford O, O'Brien L, Patti JM, Foster T. Protection against experimental Staphylococcus aureus arthritis by vaccination with clumping factor A, a novel virulence determinant. J Infect Dis. 2001;184:1572–80.

McKenney D, Pouliot KL, Wang Y, Murthy V, Ulrich M, Doring G. et al. Broadly protective vaccine for Staphylococcus aureus based on an in vivo-expressed antigen. Science. 1999;284:1523–7.

Lam H, Kesselly A, Stegalkina S, Kleanthous H, Yethon JA. Antibodies to PhnD inhibit staphylococcal biofilms. Infect Immun. 2014;82:3764–74. [PMC free article]

Gil C, Solano C, Burgui S, Latasa C, Garcia B, Toledo-Arana A. et al. Biofilm matrix exoproteins induce a protective immune response against Staphylococcus aureus biofilm infection. Infect Immun. 2014;82:1017–29. [PMC free article]

Brady RA, O'May GA, Leid JG, Prior ML, Costerton JW, Shirtliff ME. Resolution of Staphylococcus aureus biofilm infection using vaccination and antibiotic treatment. Infect Immun. 2011;79:1797–803. [PMC free article]

Gedbjerg N, LaRosa R, Hunter JG, Varrone JJ, Kates SL, Schwarz EM. et al. Anti-glucosaminidase IgG in sera as a biomarker of host immunity against Staphylococcus aureus in orthopaedic surgery patients. J Bone Joint Surg Am. 2013;95:e171. [PMC free article]

Varrone JJ, de Mesy Bentley KL, Bello-Irizarry SN, Nishitani K, Mack S, Hunter JG. et al. Passive immunization with anti-glucosaminidase monoclonal antibodies protects mice from implant-associated osteomyelitis by mediating opsonophagocytosis of Staphylococcus aureus megaclusters. J Orthop Res. 2014;32:1389–96. [PMC free article]

Shahrooei M, Hira V, Khodaparast L, Khodaparast L, Stijlemans B, Kucharikova S. et al. Vaccination with SesC decreases Staphylococcus epidermidis biofilm formation. Infect Immun. 2012;80:3660–8. [PMC free article]

Novotny LA, Jurcisek JA, Ward MO Jr, Jordan ZB, Goodman SD, Bakaletz LO. Antibodies against the majority subunit of type IV Pili disperse nontypeable Haemophilus influenzae biofilms in a LuxS-dependent manner and confer therapeutic resolution of experimental otitis media. Mol Microbiol. 2015;96:276–92. [PMC free article]

Lattar SM, Noto Llana M, Denoel P, Germain S, Buzzola FR, Lee JC. et al. Protein antigens increase the protective efficacy of a capsule-based vaccine against Staphylococcus aureus in a rat model of osteomyelitis. Infect Immun. 2014;82:83–91. [PMC free article]

Zhang J, Yang F, Zhang X, Jing H, Ren C, Cai C. et al. Protective Efficacy and Mechanism of Passive Immunization with Polyclonal Antibodies in a Sepsis Model of Staphylococcus aureus Infection. Sci Rep. 2015;5:15553. [PMC free article]

Russo TA, Beanan JM, Olson R, MacDonald U, Cox AD, St Michael F. et al. The K1 capsular polysaccharide from Acinetobacter baumannii is a potential therapeutic target via passive immunization. Infect Immun. 2013;81:915–22. [PMC free article]

Fowler VG Jr, Proctor RA. Where does a Staphylococcus aureus vaccine stand? Clin Microbiol Infect. 2014;20(Suppl 5):66–75. [PMC free article]

Shinefield H, Black S, Fattom A, Horwith G, Rasgon S, Ordonez J. et al. Use of a Staphylococcus aureus conjugate vaccine in patients receiving hemodialysis. N Engl J Med. 2002;346:491–6.

Fattom A, Matalon A, Buerkert J, Taylor K, Damaso S, Boutriau D. Efficacy profile of a bivalent Staphylococcus aureus glycoconjugated vaccine in adults on hemodialysis: Phase III randomized study. Hum Vaccin Immunother. 2015;11:632–41. [PMC free article]

Fowler VG, Allen KB, Moreira ED, Moustafa M, Isgro F, Boucher HW. et al. Effect of an investigational vaccine for preventing Staphylococcus aureus infections after cardiothoracic surgery: a randomized trial. JAMA. 2013;309:1368–78.

Capparelli EV, Bloom BT, Kueser TJ, Oelberg DG, Bifano EM, White RD. et al. Multicenter study to determine antibody concentrations and assess the safety of administration of INH-A21, a donor-selected human Staphylococcal immune globulin, in low-birth-weight infants. Antimicrob Agents Chemother. 2005;49:4121–7. [PMC free article]